Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Thrombosis Research|May 1, 1986
Antiheparin activity in human endothelial cellsH I Saba, S R Saba, G A MorelliAmerican Journal of Hematology|October 1, 1984
Effect of heparin on platelet aggregationH I Saba, S R Saba, G A MorelliAmerican Journal of Hematology|October 1, 1985
Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): studies on mechanismS R Saba, H I SabaAmerican Journal of Hematology|March 1, 1989
Spontaneous platelet aggregation in type IIB Tampa von Willebrand disease is inhibited by the 52/48-kDa fragment of normal von Willebrand factor, which contains the GPIb binding domainH I Saba, Y Fujimura, S R Saba, et al.Thrombosis Research|April 1, 1984
Endotoxin-mediated inhibition of human platelet aggregationH I Saba, S R Saba, G Morelli, et al.Blood|August 1, 1985
Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregationH I Saba, S R Saba, J Dent, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitorsH I Saba, G A Morelli, R R Azam, et al.Science (New York, N.Y.)|August 3, 1979
Heparin neutralization of PGI2: effects upon plateletsH I Saba, S R Saba, C A Blackburn, et al.Leukemia Research|March 1, 1996
Myelodysplastic syndromes in the elderly: the role of growth factors in managementH I SabaRheumatology International|January 1, 1982
In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritisT S Bocanegra, B F Germain, H I Saba, et al.Pageof 6